title: N-methyl-D-aspartate recognition site ligands modulate activity at the coupled glycine recognition site.
abstract: In synaptic plasma membranes from rat forebrain, the potencies of glycine recognition site agonists and antagonists for modulating [3H]1-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP) binding and for displacing strychnine-insensitive [3H]glycine binding are altered in the presence of N-methyl-D-aspartate (NMDA) recognition site ligands. The NMDA competitive antagonist, cis-4-phosphonomethyl-2-piperidine carboxylate (CGS 19755), reduces [3H]glycine binding, and the reduction can be fully reversed by the NMDA recognition site agonist, L-glutamate. Scatchard analysis of [3H]glycine binding shows that in the presence of CGS 19755 there is no change in Bmax (8.81 vs. 8.79 pmol/mg of protein), but rather a decrease in the affinity of glycine (KD of 0.202 microM vs. 0.129 microM). Similar decreases in affinity are observed for the glycine site agonists, D-serine and 1-aminocyclopropane-1-carboxylate, in the presence of CGS 19755. In contrast, the affinity of glycine antagonists, 1-hydroxy-3-amino-2-pyrrolidone and 1-aminocyclobutane-1-carboxylate, at this [3H]glycine recognition site increases in the presence of CGS 19755. The functional consequence of this change in affinity was addressed using the modulation of [3H]TCP binding. In the presence of L-glutamate, the potency of glycine agonists for the stimulation of [3H]TCP binding increases, whereas the potency of glycine antagonists decreases. These data are consistent with NMDA recognition site ligands, through their interactions at the NMDA recognition site, modulating activity at the associated glycine recognition site.
authors.affiliation: Searle Research and Development, Division of G. D. Searle and Company, St. Louis, MO 63198.
authors.forename: W F
authors.initials: WF
authors.lastname: Hood
authors.forename: R P
authors.initials: RP
authors.lastname: Compton
authors.forename: J B
authors.initials: JB
authors.lastname: Monahan
mesh_terms: D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D001665:Binding Sites; D001667:Binding, Competitive / Q000187:drug effects; D005971:Glutamates / Q000494:pharmacology; D018698:Glutamic Acid; D005998:Glycine / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000502:physiology; D008024:Ligands; D016202:N-Methylaspartate; D010622:Phencyclidine / Q000031:analogs & derivatives / Q000378:metabolism; D010875:Pipecolic Acids; D010880:Piperidines / Q000494:pharmacology
chemical_list: D005971:Glutamates; D008024:Ligands; D010875:Pipecolic Acids; D010880:Piperidines; D001224:Aspartic Acid; D018698:Glutamic Acid; C053672:selfotel; D016202:N-Methylaspartate; C012058:tenocyclidine; D010622:Phencyclidine; D005998:Glycine